The endocannabinoid system is a signalling network of receptors, natural chemical messengers and enzymes that runs throughout the human body and helps hold internal conditions steady. Researchers describe its main job as maintaining homeostasis, which is the body’s internal balance, and it influences mood, sleep, appetite, pain perception and immune activity. It is the system that plant cannabinoids such as THC and CBD interact with.
Last updated:
Key takeaways
- The endocannabinoid system, usually shortened to ECS, has three parts: the endocannabinoids your body makes, the CB1 and CB2 receptors they act on, and the enzymes that break them down again.
- CB1 receptors sit mainly in the brain and nervous system. CB2 receptors sit mainly on immune cells, which is why the same system touches both mood and immunity.
- The link between the ECS and sleep is real but the human evidence is still thin. A 2020 review in Current Neuropharmacology concluded that the case for targeting the ECS to treat sleep problems in older adults is inconclusive or still missing.
- Clinical endocannabinoid deficiency is a hypothesis proposed in 2001 and revisited by Ethan Russo in 2016. It is a research idea, not a diagnosis your doctor can test for.
- In South Africa, cannabis medicines containing THC are prescription only. Registering with Professor Green is the first administrative step, not a prescription and not a guarantee of eligibility.
What the endocannabinoid system actually does
The system was discovered in the early 1990s by scientists who were trying to work out why cannabis affects the brain at all. Looking for the lock that THC fits, they found a receptor network that was already there, along with the body’s own chemicals that use it. The plant did not create the system. It revealed one that had been running quietly the whole time.
A 2021 review in the International Journal of Molecular Sciences describes the ECS as primarily responsible for maintaining homeostasis, covering internal temperature, mood and immune function as well as the balance of energy going in and out. The same review lists its influence over anxiety, appetite, emotional behaviour, neuroprotection, reward, cognition, learning, memory, pain sensation and fertility.
That breadth is the point, and it is also the trap. A system that touches nearly everything is easy to oversell. You will find claims online that balancing your ECS fixes almost any complaint. The honest position is narrower: the ECS is a genuine regulatory network with strong laboratory evidence behind it, and a much smaller body of high quality human trial evidence about what happens when you deliberately change it.
The three parts of the endocannabinoid system
Every description of the ECS comes back to the same three components working as a loop: a signal, a receiver, and an off switch.
1. Endocannabinoids, the body’s own messengers
The two best studied are anandamide, sometimes called AEA, and 2-arachidonoylglycerol, usually written as 2-AG. Unlike most hormones, they are not stored in advance. They are built from fat molecules in the cell membrane at the moment they are needed, act locally, and are then broken down. That on-demand design is why the system works as a fine adjustment rather than a blunt instrument.
2. CB1 and CB2 receptors
Endocannabinoids dock onto two main receptors, and where those receptors sit explains most of what the system does.
| Feature | CB1 receptor | CB2 receptor |
|---|---|---|
| Mainly found in | Brain and central nervous system | Cells of the blood forming and immune system |
| Associated with | Mood, memory, appetite, pain signalling, sleep and wake cycles | Inflammation, immune cell behaviour, immune signalling |
| Relationship to THC | THC binds here, which is why THC is intoxicating | THC also binds here, without producing the intoxication |
| How we know | Extensive brain imaging and animal work | Largely mice bred without CB2, since no available compound binds CB2 alone |
3. Enzymes, the off switch
Two enzymes clear the messengers away once they have done their job. FAAH breaks down anandamide and MAGL breaks down 2-AG. Without them the signal would never stop, so the enzymes matter as much as the receptors. Much of the pharmaceutical interest in this field is aimed at the enzymes rather than the receptors, because slowing the breakdown raises your own endocannabinoid levels without adding an outside compound.
How the ECS shapes mood
CB1 receptors are dense in the brain regions that handle emotion, including the prefrontal cortex, the amygdala, the hippocampus and the reward circuitry. Endocannabinoids act there as a brake on other signalling, dampening a response once it has served its purpose.
The clearest example is the stress response. When a threat passes, something has to switch the alarm off, and endocannabinoid signalling is part of that shutdown. Sustained stress appears to change both endocannabinoid levels and receptor numbers over time, which is one proposed reason why long running stress and anxiety can become self sustaining.
What this does not mean is that low endocannabinoid tone has been established as the cause of anxiety or depression in people, or that raising it treats either. Those are open research questions. If your mood has been low or anxious for weeks, the first step is a proper assessment with a doctor, not a supplement or a cannabis product. Our guide to medical cannabis for anxiety in South Africa sets out what the evidence does and does not support.
The endocannabinoid system and sleep
Sleep is where the gap between mechanism and proof is widest, and it is worth being blunt about that.
The mechanism is well described. Endocannabinoid signalling interacts with the circadian clock, with the pressure to sleep that builds across a waking day, and with neurotransmitters including GABA, serotonin and adenosine. Anandamide and 2-AG show different patterns across the sleep and wake cycle in laboratory work.
The proof is another matter. A 2020 review in Current Neuropharmacology looked specifically at whether the ECS could be a therapeutic target for sleep disorders in older people, and its authors concluded that the evidence for efficacy was either inconclusive or still missing. That is a review written by researchers sympathetic to the field, and it is still that cautious.
Anyone telling you that cannabis reliably fixes sleep is going beyond the published evidence. THC can shorten the time some people take to fall asleep and can alter REM sleep, and higher amounts can make sleep quality worse rather than better. CBD’s effect on sleep appears to run partly through anxiety rather than sedation, and it can feel alerting for some people. Timing, ratio and amount all change the outcome, which is exactly why this belongs in a conversation with a prescriber. If sleep is your main concern, read our evidence review of cannabis oil for sleep in South Africa and, where snoring and daytime exhaustion are involved, the assessment of medical cannabis and sleep apnea.
The ECS and immunity
The immune side of the system runs mainly through CB2, a receptor expressed primarily by cells of the blood forming system, which includes white blood cells and the tissues that produce them.
A 2014 review in Seminars in Immunology, written by researchers who work on this receptor, makes two points worth carrying with you. First, signalling through CB2 can be either inhibitory or stimulatory depending on the biological process involved, so it is not simply an anti-inflammatory switch. Second, because no cannabinoid compound has been identified that binds CB2 and nothing else, most of what is known comes from mice genetically engineered without the receptor rather than from human trials.
That is a meaningful limitation. It means claims that cannabis boosts immunity, or that it calms immune disease, are running well ahead of the human evidence. Inflammation is also not simply bad. It is a necessary response that becomes a problem when it persists. Anyone living with an autoimmune condition, or taking immune suppressing medication, needs to raise cannabis with their treating doctor first, because interactions and timing genuinely matter.
Before you start
In South Africa, medical cannabis containing THC is prescription only through a registered doctor, usually via a SAHPRA Section 21 authorisation. This is general information for adults 18 and over, not medical advice. Speak to a doctor or pharmacist before starting, stopping or changing any treatment, especially about dosing, and tell them about every medicine you already take.
Clinical endocannabinoid deficiency: a hypothesis, not a diagnosis
You will see clinical endocannabinoid deficiency, or CECD, referred to online as though it were an established medical condition. It is not. It is a hypothesis, first proposed in 2001 and reviewed again by Ethan Russo in 2016 in the journal Cannabis and Cannabinoid Research.
The idea is that every person has a baseline endocannabinoid tone, and that in some people, whether from birth or acquired later, that tone becomes deficient and produces a recognisable cluster of symptoms. The conditions most often discussed in this context are migraine, fibromyalgia and irritable bowel syndrome, which overlap in the people they affect and share features of heightened pain sensitivity.
Russo’s 2016 paper argued that the theory had moved from speculation towards a firmer footing, pointing to statistically significant differences in anandamide levels in the cerebrospinal fluid of people with migraine, and to imaging work showing reduced ECS function in post traumatic stress disorder. That is genuine supporting evidence. It is not the same as a validated diagnosis, and there is no clinical test a South African doctor can order to measure your endocannabinoid tone. Treat CECD as an interesting research direction that may one day explain why some people with long term chronic pain respond to cannabinoids after other approaches have failed.
How THC and CBD interact with the endocannabinoid system
Plant cannabinoids work because they resemble the body’s own compounds closely enough to interact with the same machinery.
- THC binds directly to CB1 and CB2. The CB1 binding in the brain produces the intoxication, and also underlies its effects on pain perception, appetite, memory and coordination.
- CBD behaves differently. It does not bind CB1 strongly and is not intoxicating. Its effects appear to be indirect, including slowing the FAAH enzyme, which allows your own anandamide to persist longer, and acting on receptor targets outside the ECS entirely.
- Minor cannabinoids such as CBG, CBN and CBC, and the aromatic terpenes, are studied far less. Confident claims about what they do individually in humans are not yet supported.
Because CBD alters enzyme activity, it can also affect how the liver processes other medicines. That is a practical reason, not a theoretical one, to have a pharmacist or doctor review your full medicine list before anything starts. Our explainer on how to get a medical cannabis prescription in South Africa covers what that consultation involves.
Everyday habits linked to ECS function
Some ordinary lifestyle factors have been studied for their effect on endocannabinoid signalling. The evidence is strongest for exercise and weakest for diet, and none of it should be read as a treatment plan.
- Regular aerobic exercise. The best supported of the group. Sustained moderate exercise raises circulating endocannabinoid levels, and this is one of the leading explanations for the mood lift after exertion that used to be attributed to endorphins alone.
- Sleep regularity. Since ECS signalling interacts with the circadian clock, a consistent sleep and wake time is a reasonable place to start before anything pharmacological.
- Dietary fats. Endocannabinoids are built from fatty acids, so omega-3 intake has been proposed as an influence. The human evidence for changing symptoms this way is preliminary.
- Alcohol and stress load. Heavy alcohol use and sustained stress both appear to alter endocannabinoid signalling over time.
These habits are worth adopting on their own merits. Framing them as a way to fix your ECS overstates what is known.
How Professor Green fits into the process
Professor Green is a South African medical cannabis platform. It is the administrative front door to the legal access route, and it is worth being precise about the division of roles, because a lot of writing in this space blurs it.
- What registering does. Creating an account starts your access journey and gives you entry to the member area. That is the whole of what registration itself provides.
- What a doctor does. Only a registered medical practitioner can assess you, decide whether a cannabis medicine is clinically appropriate, and issue a prescription. Where an unregistered product is involved, that route runs through a SAHPRA Section 21 authorisation.
- What a pharmacy and courier do. Dispensing against a valid prescription and delivering the medicine are performed by licensed parties, not by Professor Green.
- What happens next. Registration is a step, never a guarantee. It does not promise eligibility, approval, stock or a prescription, and no platform can honestly offer those.
If reading about the endocannabinoid system has left you wondering whether the legal medical route is worth exploring, you can register for Professor Green store access and take the first step at your own pace.
Frequently asked questions about the endocannabinoid system
What is the endocannabinoid system in simple terms?
The endocannabinoid system is a signalling network of receptors, natural messenger chemicals and enzymes spread through the brain, nervous system and immune system. Its main role is maintaining homeostasis, the body’s internal balance, and it influences mood, sleep, appetite, pain perception and immune activity.
Can you test your endocannabinoid tone?
No. There is no routine clinical test in South Africa or elsewhere that measures your endocannabinoid tone. Anandamide has been measured in cerebrospinal fluid in research settings, but that is a study procedure, not a test your doctor can order.
Does the ECS control sleep?
It influences sleep rather than controls it. Endocannabinoid signalling interacts with the circadian clock and with sleep related neurotransmitters, but the 2020 Current Neuropharmacology review concluded that evidence for targeting this system to treat sleep disorders in older adults is inconclusive or still missing.
How does the ECS affect immunity?
Mainly through CB2 receptors, which are expressed primarily on cells of the blood forming and immune system. Signalling through CB2 can be either inhibitory or stimulatory depending on the process, and most current knowledge comes from mice bred without the receptor rather than from human trials.
Is clinical endocannabinoid deficiency a real diagnosis?
It is a research hypothesis, not a diagnosis. Proposed in 2001 and revisited by Ethan Russo in 2016, it suggests that low endocannabinoid tone may underlie migraine, fibromyalgia and irritable bowel syndrome. Supporting evidence exists, but no doctor can currently diagnose or test for it.
Do I need a prescription for medical cannabis in South Africa?
Yes. Cannabis medicines containing THC are prescription only and must come from a registered doctor, commonly through a SAHPRA Section 21 authorisation for unregistered medicines. Private adult use of cannabis was decriminalised by the Constitutional Court in 2018, which is a separate matter from lawful access to a cannabis medicine.
Can lifestyle changes improve ECS function?
Regular aerobic exercise has the strongest supporting evidence for raising circulating endocannabinoid levels. Consistent sleep timing, moderating alcohol and managing stress load are all reasonable habits, but describing them as fixing your ECS overstates what research currently shows.
Is CBD safe to combine with my other medicines?
Not automatically. CBD affects liver enzymes that process many common medicines, so it can change how those medicines behave. Give a doctor or pharmacist your full medicine list before starting anything containing CBD or THC.
The bottom line on the endocannabinoid system
The endocannabinoid system is real, it is important, and it is genuinely central to how the body keeps mood, sleep and immune activity in balance. It is also routinely oversold. The mechanism is far better established than the outcomes, and the honest summary is that we understand the wiring much better than we understand what happens when we deliberately adjust it in people.
That is a reason for interest rather than dismissal. If a long standing problem with pain, sleep, mood or inflammation has not responded to the usual care, discussing the legal medical cannabis route with a doctor is a reasonable next conversation to have. Go into it knowing what the research supports and what it does not, and you will ask better questions than most.
Sources and references
- Lowe H, Toyang N, Steele B, Bryant J, Ngwa W. The Endocannabinoid System: A Potential Target for the Treatment of Various Diseases. International Journal of Molecular Sciences, 31 August 2021.
- Murillo-Rodriguez E et al. The Endocannabinoid System May Modulate Sleep Disorders in Aging. Current Neuropharmacology, 2020.
- Malfitano AM, Basu S, Maresz K, Bifulco M, Dittel BN. What we know and do not know about the cannabinoid receptor 2 (CB2). Seminars in Immunology, October 2014.
- Russo EB. Clinical Endocannabinoid Deficiency Reconsidered. Cannabis and Cannabinoid Research, 2016.
- Constitutional Court of South Africa. Minister of Justice and Constitutional Development and Others v Prince, 2018.
- Parliament of South Africa. Cannabis for Private Purposes Act 7 of 2024.
- World Health Organization. Cannabis, alcohol, drugs and addictive behaviours.
- National Institute on Drug Abuse. Cannabis (Marijuana) research topic.
Explore legal medical cannabis access in South Africa
If reading about how the ECS works has made you curious about the legal route, registering is the first step. Professor Green connects you with the registered prescriber route. Registration is not a prescription and not a guarantee of eligibility.
Create Your Professor Green Account

